KIF18A and central nervous system cancer: Compared with the normal samples, except for SLAIN2, the CTTNBP2, KIF18A, NAV1, and TRIO protein expression in glioma was elevated, while SRCIN1 and TTBK2 were decreased (Figure 6Q).